A Lancet Psychiatry network meta-analysis of ADHD pharmacotherapy exposes therapeutic inertia and uncritical dose escalation as twin hazards—with direct…
Intensive dose management sounds like a great solution to the issues mentioned in the article - only problem is that requires more regular visits and reviews by doctors. That’s both financially impossible for most patients, and frankly impossible to achieve widely with specialist shortages.
Yes and if I understand it correctly a point made in the arcticle is that studies often evaluate either on too rigid of a dosing management schedule or the dosing adjustment is unrealistically responsive to real world experience for people seeking ADHD medication.
Intensive dose management sounds like a great solution to the issues mentioned in the article - only problem is that requires more regular visits and reviews by doctors. That’s both financially impossible for most patients, and frankly impossible to achieve widely with specialist shortages.
Yes and if I understand it correctly a point made in the arcticle is that studies often evaluate either on too rigid of a dosing management schedule or the dosing adjustment is unrealistically responsive to real world experience for people seeking ADHD medication.